NAGE · Company research
Niagen Bioscience, Inc. Common Stock (NAGE): Valuation Analysis
Available valuation snapshots and ratios; unavailable metrics remain blank.
RESEARCH CONTEXT
Understand the numbers
Available valuation snapshots and ratios; unavailable metrics remain blank. Use period, currency, units and source fields when interpreting values.
1records availableBasic Materials
Valuation Analysis data
Database-backed records only
| valuation date | price | market cap | enterprise value | pe | forward pe | peg | price sales | price book | price fcf |
|---|---|---|---|---|---|---|---|---|---|
| Oct 8, 2026 | 2.72 | $248,752,520 | 182012520.00 | 298.0000000000000000 | — | — | 8.3516038274299144 | 3.0141590732842187 | 92.71431979127841968903 |
Informational research only, not financial advice. Forecasts are uncertain and can be wrong.